Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients.
about
Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countriesBarrett's oesophagus: frequency and prediction of dysplasia and cancerNSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.The Role of Gastroesophageal Reflux and Other Factors during Progression to Esophageal AdenocarcinomaProton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis.Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus.Proton Pump Inhibitors: The Culprit for Barrett's Esophagus?Deoxycholic acid promotes development of gastroesophageal reflux disease and Barrett's oesophagus by modulating integrin-αv trafficking.Dietary sugar and Barrett's esophagus.An evolutionary perspective on field cancerization.Precision care for Barrett's esophagus
P2860
Q26799758-F8973F86-0A37-4301-8F06-4459D0B736CBQ28080794-B9726C92-3112-4653-9386-E7B6CACDA7E4Q35046884-C37D7747-13EB-43CF-BB95-99EAD1FD5A1FQ35666515-D75636C2-7834-49DE-B67A-C37DCAA2FAE6Q35815874-C374FFEE-B0CA-49F0-91C1-F58FF7A430E3Q36245569-26E36E23-2781-4C88-A818-EEEC4CA70690Q36570868-5DA11F51-39D3-4750-8147-7BDA1FF42159Q37702201-B5B338C1-0D2D-4D3C-84DA-5ECED46AA7EFQ38332589-3C4B9240-4A91-46B2-9458-01B304A8B35BQ47095372-A3E24D42-0B2E-44D8-94C2-CC2D1E59AC43Q47109998-25AEAFEF-ACC2-43C2-97DF-1554BF10214DQ50020845-B700979A-B574-4634-982B-D54AD3DE1A85Q58554442-E347B744-1837-456D-9E47-F0418BA5FFC6
P2860
Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Proton pump inhibitor use may ...... onwide study of 9883 patients.
@en
Proton pump inhibitor use may ...... onwide study of 9883 patients.
@nl
type
label
Proton pump inhibitor use may ...... onwide study of 9883 patients.
@en
Proton pump inhibitor use may ...... onwide study of 9883 patients.
@nl
prefLabel
Proton pump inhibitor use may ...... onwide study of 9883 patients.
@en
Proton pump inhibitor use may ...... onwide study of 9883 patients.
@nl
P2093
P2860
P356
P1476
Proton pump inhibitor use may ...... onwide study of 9883 patients.
@en
P2093
F Hvid-Jensen
L Pedersen
P Funch-Jensen
P2860
P304
P356
10.1111/APT.12693
P407
P577
2014-03-11T00:00:00Z